Results of Tender Offer
Summary by AI BETAClose X
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, IN ANY MEMBER STATE OF THE EEA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION.
Legal Entity Identifier: 2138008X94M7OVE73l77
25 September 2026
Schroders Capital Global Innovation Trust plc
("INOV" or the "Company")
Results of Tender Offer
Tender Offer Results
The Board today announces the results of the Tender Offer, details of which were set out in a circular to Shareholders published by the Company on 7 May 2026 (the "Circular") and the announcement of 22 June 2026. The Tender Offer was approved by Shareholders at a general meeting of the Company held at 1.30 p.m. on 2 June 2026 and the Tender Offer closed at 1.00 p.m. on 23 September 2026.
A total of 457,274,764 Ordinary Shares, representing 71.97 per cent. of the Ordinary Shares in issue as at the Record Date (excluding Ordinary Shares held in treasury), were validly tendered under the Tender Offer. As a result, the Tender Offer was oversubscribed.
The Company will purchase a total of 124,276,792 Ordinary Shares. Shareholders who validly tendered such number of Ordinary Shares equal to or less than their Basic Entitlement shall have all tendered Ordinary Shares purchased in full. Following a scale-back exercise, Shareholders who validly tendered such number of Ordinary Shares greater than their Basic Entitlement will have a number of Ordinary Shares equal to their Basic Entitlement purchased in full plus 1.591332227 per cent. of their Excess Applications, in accordance with the terms of the Tender Offer set out in the Circular.
Total Voting Rights
Following the completion of the Tender Offer, the Company will have 511,085,133 Ordinary Shares in issue, with no Ordinary Shares held in treasury. Therefore, the total number of voting rights in the Company will be 511,085,133 and this figure may be used by Shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Defined terms used in this announcement shall, unless the context requires otherwise, have the meanings ascribed to them in the Circular.
Enquiries:
Schroder Investment Management Limited
Francesca Davis (Company Secretary) 0207 658 6000
Charlotte Banks (Press) 0207 658 9063
John Spedding (Head of Investment Trusts) 0207 658 3206
Winterflood, a division of Marex
Neil Langford / Rose Ramsden (Corporate Finance) 020 3100 0000
Darren Willis / Innes Urquhart (Corporate Sales)
IMPORTANT INFORMATION
This announcement contains forward-looking statements. These forward-looking statements include all matters that are not historical facts. These forward-looking statements are made based upon the Company's expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. Forward-looking statements are not guarantees of future performance, and the Company's actual results of operations, financial condition and liquidity may differ materially and adversely from the forward-looking statements contained in this announcement. Forward-looking statements speak only as of the day they are made and the Company does not undertake to update its forward-looking statements unless required by law.
Any acceptance or other response to the Tender Offer should be made only on the basis of information contained in or referred to in the Circular. The Circular contains important information, including the full terms and conditions of the Tender Offer, which Shareholders are urged to read carefully.
Marex Financial ("Marex") is authorised and regulated in the United Kingdom by the FCA, and is acting exclusively for the Company and no-one else in relation to the Tender Offer or the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Marex nor for providing advice in relation to the Tender Offer or the matters referred to in this announcement. Nothing in this paragraph shall serve to exclude or limit any responsibilities which Marex may have under FSMA or the regulatory regime established thereunder.
Overseas Shareholders
The distribution of this announcement in certain jurisdictions may be restricted by law. It is the responsibility of all Overseas Shareholders to satisfy themselves as to the observance of any legal requirements in their jurisdiction, including, without limitation, any relevant requirements in relation to the ability of such holders to participate in the Tender Offer.
Notice for U.S. Shareholders
The Tender Offer relates to securities in a non-US company which is registered in England and Wales and listed on the London Stock Exchange and is subject to the disclosure requirements, rules and practices applicable to companies listed in the United Kingdom, which differ from those of the United States in certain material respects. The Circular has been prepared in accordance with UK style and practice for the purpose of complying with English law and the rules of the FCA and of the London Stock Exchange. US Shareholders should read the entire Circular. The financial information relating to the Company included in the Circular has not been prepared in accordance with generally accepted accounting principles in the United States and thus may not be comparable to financial information relating to US companies. The Tender Offer is not subject to the disclosure and other procedural requirements of Regulation 14D under the Exchange Act. The Tender Offer will be made in the United States pursuant to Section 14(e) of, and Regulation 14E under, the Exchange Act, subject to the exemptions provided by Rule 14d-1(d) thereunder and otherwise in accordance with the requirements of the rules of the FCA. Accordingly, the Tender Offer will be subject to disclosure and other procedural requirements that are different from those applicable under US domestic tender offer procedures and law. US Shareholders should note that the Company is not listed on a US securities exchange, subject to the periodic reporting requirements of the Exchange Act or required to, and does not, file any reports with the SEC thereunder.
It may be difficult for US Shareholders to enforce certain rights and claims arising in connection with the Tender Offer under US federal securities laws since the Company is located outside the United States and its officers and directors reside outside the United States. It may not be possible to sue a non-US company or its officers or directors in a non-US court for violations of US securities laws. It also may not be possible to compel a non-US company or its affiliates to subject themselves to a US court's judgment.
To the extent permitted by applicable law and in accordance with normal UK practice, the Company, Marex or any of their affiliates, may make certain purchases of, or arrangements to purchase, Shares outside the United States during the period in which the Tender Offer remains open for acceptance, including sales and purchases of Shares effected by Marex acting as market maker in the Shares. These purchases, or other arrangements, may occur either in the open market at prevailing prices or in private transactions at negotiated prices. In order to be excepted from the requirements of Rule 14e-5 under the Exchange Act by virtue of Rule 14e-5(b)(12) thereunder, such purchases, or arrangements to purchase, must comply with the applicable English law and regulation, including the UK Listing Rules, and the relevant provisions of the Exchange Act. Any such purchases by Marex or its affiliates will not be made at prices higher than the price of the Tender Offer provided in the Circular, unless the price of the Tender Offer is increased accordingly. In addition, in accordance with normal UK market practice, Marex and its affiliates may continue to act as market makers in the Shares and may engage in certain other purchasing activities consistent with their respective normal and usual practice and applicable law. Any information about such purchases will be disclosed as required in the UK and the United States and, if required, will be reported via the Regulatory Information Service and available on the London Stock Exchange website at http://www.londonstockexchange.com.
The receipt of cash pursuant to the Tender Offer may be a taxable transaction for US federal income tax purposes. In addition, holders may be subject to US backup withholding and information reporting on payments with respect to the Tender Offer made (or deemed made) within the United States.
Neither the Tender Offer nor the Circular have been approved, disapproved or otherwise recommended by the SEC, any US state securities commission or any other US regulatory authority, nor have such authorities passed upon the merits or fairness of the Tender Offer or determined the adequacy of the information contained in the Circular. Any representation to the contrary is a criminal offence.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Frasers Group
- 2 hours ago Cavendish Financial
- 2 hours ago Diaceutics
- 2 hours ago AB Dynamics
- 15 hours ago Johnson Matthey